Hopes were high a decade ago, when a new class of drugs called BET inhibitors emerged for treating blood cancers and solid tumors. Since then, however, results from numerous clinical trials have painted a much more complex ...
Sep 10, 2024
0
17
In a pioneering study, Dr. Patrick Krauss and Dr. Achim Schilling from the Cognitive Computational Neuroscience Group at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) have used artificial intelligence to gain ...
Sep 10, 2024
0
19
Around 58 million people suffer from chronic inflammation caused by the hepatitis C virus, and 300,000 people die from the disease every year.
Sep 9, 2024
0
6
A study presented today at the International Association for the Study of Lung Cancer 2024 World Conference on Lung Cancer demonstrates a promising pathway toward developing predictive biomarkers for immune checkpoint inhibitors.
Sep 7, 2024
0
0
